Drug
Exparel 266 MG Per 20 ML Injection
Exparel 266 MG Per 20 ML Injection is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
1
17%
Ph phase_4
5
83%
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution6 total trials
Phase 4Post-market surveillance
5(83.3%)
N/ANon-phased studies
1(16.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 45 (83.3%)
N/A1 (16.7%)
Trials by Status
enrolling_by_invitation117%
completed350%
unknown233%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_4
Pectoralis and Serratus Muscle Blocks
NCT03743194
enrolling_by_invitationphase_4
Liposomal Bupivacaine With Dexamethasone for Foot Surgery
NCT06465992
completedphase_4
Exparel Use in Bilateral TAP Blocks for Postoperative Pain Control
NCT03878888
completedphase_4
The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery
NCT03196505
unknownphase_4
Use of Exparel for Postoperative Analgesia Following Bariatric Surgery
NCT03975283
Clinical Trials (6)
Showing 6 of 6 trials
NCT03743194Phase 4
Pectoralis and Serratus Muscle Blocks
NCT06465992Phase 4
Liposomal Bupivacaine With Dexamethasone for Foot Surgery
NCT03878888Phase 4
Exparel Use in Bilateral TAP Blocks for Postoperative Pain Control
NCT03196505Phase 4
The Effect of Liposomal Bupivacaine on Post Operative Pain and Narcotic Use After Bariatric Surgery
NCT03975283Phase 4
Use of Exparel for Postoperative Analgesia Following Bariatric Surgery
NCT03927326Not Applicable
Postoperative Analgesia in Laparoscopic Abdominal Surgery After Exparel Via TAP or Local Infiltration
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6